1451 related articles for article (PubMed ID: 23448451)
21. The kidney in Fabry's disease.
Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
[TBL] [Abstract][Full Text] [Related]
22. Fabry disease.
Germain DP
Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
[TBL] [Abstract][Full Text] [Related]
23. Anderson-Fabry disease: developments in diagnosis and treatment.
Kes VB; Cesarik M; Zavoreo I; Madzar Z; Demarin V
Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
[TBL] [Abstract][Full Text] [Related]
24. Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease.
Sessa A; Meroni M; Battini G; Righetti M; Mignani R
Semin Nephrol; 2004 Sep; 24(5):532-6. PubMed ID: 15490423
[TBL] [Abstract][Full Text] [Related]
25. [The neurological manifestations of Fabry disease. A review].
Firsov KV; Kotov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
[TBL] [Abstract][Full Text] [Related]
26. Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation.
Lavalle L; Thomas AS; Beaton B; Ebrahim H; Reed M; Ramaswami U; Elliott P; Mehta AB; Hughes DA
PLoS One; 2018; 13(4):e0193550. PubMed ID: 29621274
[TBL] [Abstract][Full Text] [Related]
27. Cardiac manifestations of Anderson-Fabry disease in heterozygous females.
Kampmann C; Baehner F; Whybra C; Martin C; Wiethoff CM; Ries M; Gal A; Beck M
J Am Coll Cardiol; 2002 Nov; 40(9):1668-74. PubMed ID: 12427421
[TBL] [Abstract][Full Text] [Related]
28. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
[TBL] [Abstract][Full Text] [Related]
30. Fabry disease and cardiovascular involvement.
Anastasakis A; Papatheodorou E; Steriotis AK
Curr Pharm Des; 2013; 19(33):5997-6008. PubMed ID: 23448453
[TBL] [Abstract][Full Text] [Related]
31. The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
Verrecchia E; Zampetti A; Antuzzi D; Ricci R; Ferri L; Morrone A; Feliciani C; Dagna L; Manna R
Eur J Intern Med; 2016 Jul; 32():26-30. PubMed ID: 27083555
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.
Zampetti A; Gnarra M; Borsini W; Giurdanella F; Antuzzi D; Piras A; Smaldone C; Pieroni M; Cadeddu C; de Waure C; Feliciani C
Cytokine; 2013 Mar; 61(3):933-9. PubMed ID: 23332617
[TBL] [Abstract][Full Text] [Related]
33. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
34. Fabry disease - Vascular manifestations.
Karetova D; Bultas J; Dostalova G; Palecek T; Kovarnik T; Golan L; Linhart A
Vasa; 2010 May; 39(2):123-31. PubMed ID: 20464667
[TBL] [Abstract][Full Text] [Related]
35. Cardiac Involvement in Fabry Disease and the Role of Multimodality Imaging in Diagnosis and Disease Monitoring.
Umer M; Motwani M; Jefferies JL; Nagueh SF; Kalra DK
Curr Probl Cardiol; 2023 Jan; 48(1):101439. PubMed ID: 36202174
[TBL] [Abstract][Full Text] [Related]
36. [Neurological complications of Fabry-disease].
Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
[TBL] [Abstract][Full Text] [Related]
37. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
38. Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening.
Chen Z; Yin B; Jiao J; Ye T
BMC Nephrol; 2024 Feb; 25(1):61. PubMed ID: 38383316
[TBL] [Abstract][Full Text] [Related]
39. Fabry disease: A fundamental genetic modifier of cardiac function.
Tadevosyan A
Curr Res Transl Med; 2017; 65(1):10-14. PubMed ID: 28340691
[TBL] [Abstract][Full Text] [Related]
40. Cardiac manifestations in Fabry disease.
Linhart A; Lubanda JC; Palecek T; Bultas J; Karetová D; Ledvinová J; Elleder M; Aschermann M
J Inherit Metab Dis; 2001; 24 Suppl 2():75-83; discussion 65. PubMed ID: 11758683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]